Zydus Partners MSN To Launch First US Generic Of Adempas

Zydus with MSN launched first generic Adempas (riociguat tablets) in US across all five strengths for PAH and CTEPH, developed and manufactured by MSN after USFDA approval as generic equivalent; Bayer reported global Adempas sales of about EUR745m in 2025.